Fabtech Technologies Submits Q4FY26 SEBI Compliance Certificate to Stock Exchanges

1 min read     Updated on 06 Apr 2026, 07:21 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Fabtech Technologies Limited filed its Q4FY26 compliance certificate under SEBI Regulation 74(5) with NSE and BSE on April 06, 2026. The certificate from RTA Bigshare Services Private Limited confirms the regulation is not applicable as all company shares remain in demat form, with no rematerialisation requests received during the quarter ended March 31, 2026.

powered bylight_fuzz_icon
37029065

*this image is generated using AI for illustrative purposes only.

Fabtech Technologies Limited has submitted its quarterly compliance certificate to the National Stock Exchange of India Limited and BSE Limited for the quarter ended March 31, 2026. The filing, made on April 06, 2026, pertains to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Certificate

The certificate was issued by Bigshare Services Private Limited, the company's Registrar and Transfer Agent (RTA), dated April 04, 2026. The document confirms that Regulation 74(5) of SEBI regulations is not applicable to Fabtech Technologies Limited during the specified quarter.

Parameter Details
Quarter Period March 31, 2026
Filing Date April 06, 2026
Certificate Date April 04, 2026
Registrar Bigshare Services Private Limited
Reference Number BSS/SE-AU-030

Share Dematerialization Status

According to the certificate issued by Bigshare Services Private Limited, the entire holding of Fabtech Technologies Limited's shares remains in dematerialized (demat) form. The RTA confirmed that no requests were received from any company members for rematerialisation during the quarter ended March 31, 2026.

This complete digitization of shareholding indicates the company's adherence to modern trading practices and regulatory requirements. The absence of rematerialisation requests suggests shareholder satisfaction with the electronic format of share certificates.

Corporate Information

The filing was signed by Hemant Mohan Anavkar, Executive Director of Fabtech Technologies Limited, bearing DIN: 00150776. The company maintains its registered office at 715, Janki Centre, Off. Veera Desai Road, Andheri West, Mumbai, Maharashtra, 400053.

Contact Details Information
Phone +91 22 65540300
Email cs@fabtechnologies.com
Website fabtechnologies.com
Corporate Address 1st Floor, ABR Emerald, Plot No. D8, Street 16, MIDC Andheri East, Chakala, Mumbai, Maharashtra, 400093

The quarterly certificate submission demonstrates Fabtech Technologies Limited's commitment to regulatory compliance and transparent corporate governance practices. The confirmation of complete share dematerialization reflects the company's alignment with digital financial infrastructure and modern market practices.

Historical Stock Returns for Fabtech Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-0.01%+2.88%+7.47%-22.32%-14.20%-14.20%

What strategic initiatives might Fabtech Technologies pursue in the upcoming quarters given their strong regulatory compliance track record?

How could the complete dematerialization of shares position Fabtech Technologies for potential institutional investor interest or market expansion?

Will Fabtech Technologies consider leveraging their digital-first approach to explore new fintech partnerships or blockchain-based share trading solutions?

Fabtech Technologies Reports Consolidated Order Book Over ₹900 Crore

1 min read     Updated on 04 Apr 2026, 04:40 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Fabtech Technologies Limited announced strong business performance with consolidated order book exceeding ₹900 crore as of March 31, 2026. Despite facing global market challenges including logistics disruptions and input cost escalations, the company secured strategic projects across animal health, vaccine, and pharmaceutical sectors in Saudi Arabia and Africa, demonstrating resilience and expanding market presence.

powered bylight_fuzz_icon
36845945

*this image is generated using AI for illustrative purposes only.

Fabtech Technologies Limited has reported strong business performance with its consolidated order book exceeding ₹900 crore as of March 31, 2026. The company announced these updates in a corporate communication to stock exchanges, highlighting its resilience amid challenging global market conditions.

Strong Order Book Performance

The company's financial position remains robust despite facing significant external challenges during the year. Global volatility, including disruptions in logistics and freight movements, along with cost escalations across key inputs, marked the closing year. However, Fabtech Technologies demonstrated the strength of its execution model by minimizing the impact of these transient challenges on its overall performance.

Performance Metric: Details
Consolidated Order Book: More than ₹900 crore
Reporting Period: Year ended March 31, 2026
Market Challenges: Logistics disruptions, freight issues, input cost escalations

Strategic Project Acquisitions

During the year, Fabtech Technologies secured several high-impact projects that strengthen its market positioning across diverse sectors and geographies. These strategic wins demonstrate the company's ability to expand into new segments while maintaining its core competencies.

The company achieved significant milestones in three key areas:

  • Animal Health Segment: Successfully entered and expanded operations in the growing animal health market
  • Saudi Arabia Projects: Secured vaccine and advanced pharmaceutical projects in the Kingdom of Saudi Arabia
  • African Operations: Won large-scale pharmaceutical and infrastructure projects across multiple African markets

Market Positioning and Growth Strategy

These strategic developments reinforce Fabtech Technologies' positioning in high-growth sectors and geographies while strengthening its global execution platform. The company's ability to secure complex, value-accretive projects across diverse markets demonstrates its operational capabilities and market reach.

Strategic Development: Sector Geography
Animal Health Expansion: Healthcare/Veterinary Multiple markets
Vaccine Projects: Pharmaceuticals Saudi Arabia
Infrastructure Projects: Pharmaceuticals/Infrastructure Africa

Future Outlook

Looking ahead, Fabtech Technologies remains optimistic about its growth trajectory. The company's confidence is supported by several key factors including its robust order book, expanding market presence, and continued focus on complex, value-accretive projects. The strategic positioning across high-growth sectors and geographies provides a strong foundation for future expansion.

The company indicated that detailed financial results will be announced in due course, with this update serving to provide stakeholders with a broad directional view of performance for the year ended March 31, 2026.

Historical Stock Returns for Fabtech Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-0.01%+2.88%+7.47%-22.32%-14.20%-14.20%

How will Fabtech Technologies' expansion into the animal health segment impact its revenue mix and margins in the coming years?

What specific opportunities does the Saudi Arabia vaccine project pipeline present for further Middle East market penetration?

Could the company's success in African pharmaceutical infrastructure projects position it for similar opportunities in other emerging markets?

More News on Fabtech Technologies

1 Year Returns:-14.20%